Abiopharma

🔍 vant Hoff Graham (Director)

Company: AleAnna, Inc. (ANNA)

Report Date: 2026-04-13

Detailed Transactions and Holdings:

• Acquired 46,809 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-13 | Code: A | equity_swap_involved: 0 | shares_owned_after: 148,504.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1

Footnotes:

• F1: Represents restricted stock units ("RSUs") granted by AleAnna, Inc. (the "Issuer") to the reporting person pursuant to the AleAnna, Inc. 2025 Long-Term Incentive Plan and represents a contingent right to receive one share of common stock of the Issuer or its cash equivalent, as determined at the time of settlement by the Compensation Committee of the Issuer's Board of Directors. The RSUs vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the next annual meeting of stockholders, provided that such annual meeting of the stockholders occurs at least 52 weeks following the prior annual meeting of the stockholders, and further provided that the reporting person is employed by or providing services to the Issuer on such date.